Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Apr 30, 2024 | 14.96 | -4.47 |
Oak Valley Bancorp | OVLY | Apr 30, 2024 | 24.15 | -1.67 |
Oak Woods Acquisition | OAKU | Apr 30, 2024 | 10.77 | 0.00 |
Oaktree Capital A Pref | OAK-A | Apr 30, 2024 | 21.80 | +0.14 |
Oaktree Capital Group B Pref | OAK-B | Apr 30, 2024 | 21.50 | -0.05 |
Oaktree Specialty | OCSL | Apr 30, 2024 | 19.16 | -3.57 |
Oatly ADR | OTLY | Apr 30, 2024 | 1.15 | +15.00 |
Oblong | OBLG | Apr 30, 2024 | 0.11 | -5.00 |
OCA Acquisition A | OCAX | Apr 30, 2024 | 10.95 | 0.00 |
Occidental Petroleum | OXY | Apr 30, 2024 | 66.14 | -3.06 |
Ocean Biomedical | OCEA | Apr 30, 2024 | 1.40 | -10.83 |
Ocean Power Technologies | OPTT | Apr 30, 2024 | 0.19 | -3.50 |
Oceaneering International | OII | Apr 30, 2024 | 22.91 | -5.95 |
OceanFirst Financial | OCFC | Apr 30, 2024 | 14.76 | -1.53 |
OceanFirst Pref | OCFCP | Apr 30, 2024 | 24.50 | +1.53 |
OceanPal | OP | Apr 30, 2024 | 2.42 | -1.83 |
Ocugen | OCGN | Apr 30, 2024 | 1.32 | -5.04 |
Ocular Therapeutix | OCUL | Apr 30, 2024 | 4.74 | -1.25 |
Oculis | OCS | Apr 30, 2024 | 13.07 | +2.67 |
Ocuphire Pharma | OCUP | Apr 30, 2024 | 1.59 | -3.94 |
Ocwen Financial | OCN | Apr 30, 2024 | 23.34 | -5.24 |
Oddity Tech | ODD | Apr 30, 2024 | 32.54 | -0.03 |
Odyssey Marine Exploration | OMEX | Apr 30, 2024 | 3.67 | +4.26 |
Offerpad Solutions A | OPAD | Apr 30, 2024 | 7.77 | +2.37 |
Office Properties | OPI | Apr 30, 2024 | 2.02 | -3.35 |
OFG Bancorp | OFG | Apr 30, 2024 | 36.11 | -0.50 |
OFS Capital | OFS | Apr 30, 2024 | 9.70 | +1.89 |
OFS Credit | OCCI | Apr 30, 2024 | 7.02 | -0.43 |
OFS Credit C Pref | OCCIO | Apr 30, 2024 | 23.98 | +0.93 |
OFS Credit E Pref | OCCIN | Apr 30, 2024 | 22.89 | -0.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.